LEXICON PHARMACEUTICALS, INC. (LXRX) › Operating Cash FlowLEXICON PHARMACEUTICALS, INC. (LXRX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: -$89.02M2010: -$82.37M2011: -$87.94M2012: -$94.46M2013: -$91.08M2014: -$75.62M2015: $184.78M2016: -$175.63M2017: -$185.39M2018: -$148.61M2019: $113.81M2020: -$142.97M2021: -$87.02M2022: -$88.85M2023: -$161.90M2024: -$178.78M2025: -$67.85M-$67.85M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$67.85M+62.0%2024-$178.78M-10.4%2023-$161.90M-82.2%2022-$88.85M-2.1%2021-$87.02M+39.1%2020-$142.97M-225.6%2019$113.81M+176.6%2018-$148.61M+19.8%2017-$185.39M-5.6%2016-$175.63M-195.0%2015$184.78M+344.3%2014-$75.62M+17.0%2013-$91.08M+3.6%2012-$94.46M-7.4%2011-$87.94M-6.8%2010-$82.37M+7.5%2009-$89.02M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share